FDA approves first extended depth of focus lenses for people with cataracts

pharmafile | July 18, 2016 | News story | Research and Development, Sales and Marketing Abbott, FDA, cataracts 

Abbott has announced that the Tecnis Symfony Intraocular Lenses for the treatment of cataracts has been approved by the US Food and Drug Administration.

The lens becomes the first intraocular lens that provides cataract patients with an extended depth-of-focus, which helps improve their sharpness of vision at near, intermediate and far distances.

Almost four million cataract surgeries are performed in the US each year and, by the age of 80, more than half of all Americans either have a cataract or have had cataract surgery.

Advertisement

In clinical studies, it has been shown that the Symfony lens provided seamless day-to-night vision and demonstrated a low incidence of halo and glare.

Eric D. Donnenfeld, a New York-based ophthalmic consultant, says: “Many of my patients live very active lifestyles and want to see clearly at all distances, and without glasses if possible. With the Symfony lens, I can give patients the freedom to enjoy the activities that matter to them, while wearing glasses less.”

Thomas Frinzi, senior vice president of Abbott’s vision business, adds: “This is an important addition to our portfolio of lenses, as we expect many patients to choose a Symfony lens over a standard monofocal lens, given its benefits. We are happy that we can offer more people around the world this new category of lenses.”

Sean Murray

Related Content

Johnson & Johnson submits robotic surgical system for De Novo classification

Johnson & Johnson has announced the submission of its Ottava Robotic Surgical System for De …

MedPharm announces US FDA inspection of North Carolina manufacturing facility

MedPharm has announced that the US Food and Drug Administration (FDA) has completed a successful …

Rethinking oncology trial endpoints with generalised pairwise comparisons

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival …

The Gateway to Local Adoption Series

Latest content